These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 12968095)
1. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. Brancazio LR; Murtha AP; Heine RP N Engl J Med; 2003 Sep; 349(11):1087-8; author reply 1087-8. PubMed ID: 12968095 [No Abstract] [Full Text] [Related]
2. 17-α hydroxyprogesterone caproate for the prevention of preterm birth. Gupta S; Roman AS Womens Health (Lond); 2012 Jan; 8(1):21-30. PubMed ID: 22171770 [TBL] [Abstract][Full Text] [Related]
3. Inefficacy of 17 alpha-hydroxyprogesterone caproate in the prevention of prematurity in twin pregnancy. Hartikainen-Sorri AL; Kauppila A; Tuimala R Obstet Gynecol; 1980 Dec; 56(6):692-5. PubMed ID: 7443111 [TBL] [Abstract][Full Text] [Related]
7. Prevention of preterm delivery with 17-hydroxyprogesterone caproate: pharmacologic considerations. Feghali M; Venkataramanan R; Caritis S Semin Perinatol; 2014 Dec; 38(8):516-22. PubMed ID: 25256193 [TBL] [Abstract][Full Text] [Related]
8. Prevention of preterm delivery after successful tocolysis in preterm labor by 17 alpha-hydroxyprogesterone caproate: a randomized controlled trial. Rozenberg P; Chauveaud A; Deruelle P; Capelle M; Winer N; Desbrière R; Perrotin F; Bohec C; Connan L; Vayssière C; Langer B; Mantel A; Azimi S; Porcher R; Azria E; Am J Obstet Gynecol; 2012 Mar; 206(3):206.e1-9. PubMed ID: 22381603 [TBL] [Abstract][Full Text] [Related]
9. Prevention of premature labor by 17 alpha-hydroxyprogesterone caproate. Yemini M; Borenstein R; Dreazen E; Apelman Z; Mogilner BM; Kessler I; Lancet M Am J Obstet Gynecol; 1985 Mar; 151(5):574-7. PubMed ID: 3976757 [TBL] [Abstract][Full Text] [Related]
10. Use of hydroxyprogesterone caproate to prevent preterm labour in uterine didelphys: a case report. Ng KS; Ng BK; Lim PS; Shafiee MN; Abdul Karim AK; Omar MH Horm Mol Biol Clin Investig; 2016 Sep; 27(3):89-91. PubMed ID: 26684353 [TBL] [Abstract][Full Text] [Related]
11. Prophylaxis with 17 alpha-hydroxyprogesterone caproate for prevention of recurrent preterm delivery: does gestational age at initiation of treatment matter? How HY; Barton JR; Istwan NB; Rhea DJ; Stanziano GJ Am J Obstet Gynecol; 2007 Sep; 197(3):260.e1-4. PubMed ID: 17826411 [TBL] [Abstract][Full Text] [Related]
13. Recurrent hope for the treatment of preterm delivery. Doggrell SA Expert Opin Pharmacother; 2003 Dec; 4(12):2363-6. PubMed ID: 14640934 [TBL] [Abstract][Full Text] [Related]
14. A comparative study of the efficiency of hydroxyprogesterone caproate and of chlormadinone acetate in the prevention of premature labor. Bréart G; Lanfranchi M; Chavigny C; Rumeau-Rouquette C; Sureau C Int J Gynaecol Obstet; 1979; 16(5):381-4. PubMed ID: 86468 [TBL] [Abstract][Full Text] [Related]
15. 17-alpha hydroxyprogesterone caproate for preterm birth prevention: Where have we been, how did we get here, and where are we going? Manuck TA Semin Perinatol; 2017 Dec; 41(8):461-467. PubMed ID: 28947068 [TBL] [Abstract][Full Text] [Related]
16. Suppression of threatened premature labor by administration of cortisol and 17 alpha-hydroxyprogesterone caproate: a comparison with ritodrine. Kauppila A; Hartikainen-Sorri AL; Jänne O; Tuimala R; Järvinen PA Am J Obstet Gynecol; 1980 Oct; 138(4):404-8. PubMed ID: 7424996 [TBL] [Abstract][Full Text] [Related]
20. Pharmacological use of progesterone and 17-alpha-hydroxyprogesterone caproate in the prevention of preterm delivery. Facchinetti F; Vaccaro V Minerva Ginecol; 2009 Oct; 61(5):401-9. PubMed ID: 19749671 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]